| Dr Brian Douglas Lawenda, MD | |
|
7379 W Deschutes Ave, Suite 100, Kennewick, WA 99336-7900 | |
| (509) 987-1800 | |
| (509) 987-1808 |
| Full Name | Dr Brian Douglas Lawenda |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 27 Years |
| Location | 7379 W Deschutes Ave, Kennewick, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104896794 | NPI | - | NPPES |
| P00894440 | Other | RAILROAD MEDICARE | |
| 01371595 | Other | NV | AMERIGROUP |
| 500708662 | Medicaid | OR | |
| 518641 | Medicaid | AZ | |
| 7839863 | Other | NV | AETNA |
| 1457283 | Other | NV | GHI |
| 4738395 | Other | WA | CIGNA |
| 1104896794 | Medicaid | NV | |
| 7839863 | Other | WA | AETNA |
| 1104896794 | Medicaid | WA | |
| P01650856 | Other | WA | RR MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kadlec Regional Medical Center | Richland, WA | Hospital |
| Lourdes Medical Center | Pasco, WA | Hospital |
| Prosser Memorial Hospital | Prosser, WA | Hospital |
| Trios Health | Kennewick, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Cancer Care Associates Pc | 5193036390 | 3 |
News Archive
UNICEF warned today that serious funding shortfalls are jeopardizing its humanitarian operation in Pakistan. UNICEF is extremely concerned at the lack of funds for its water and sanitation operation, with millions of children at risk from water-borne diseases.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
Drug delivery company pSivida Corp today announced it amended and restated its Research and Development Agreement with Pfizer Inc. to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and glaucoma.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary Phase 2 data describing the methodology used to define an imaging protocol for a one-day rest-stress myocardial perfusion imaging test using its novel investigational PET imaging agent flurpiridaz F 18 injection (formerly known as BMS747158).
A new review showed that the protective effect of prior SARS-CoV-2 infection is at least equivalent to that of vaccination.
› Verified 4 days ago
| Entity Name | Northwest Cancer Care Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164810545 PECOS PAC ID: 5193036390 Enrollment ID: O20150615001025 |
News Archive
UNICEF warned today that serious funding shortfalls are jeopardizing its humanitarian operation in Pakistan. UNICEF is extremely concerned at the lack of funds for its water and sanitation operation, with millions of children at risk from water-borne diseases.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
Drug delivery company pSivida Corp today announced it amended and restated its Research and Development Agreement with Pfizer Inc. to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and glaucoma.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary Phase 2 data describing the methodology used to define an imaging protocol for a one-day rest-stress myocardial perfusion imaging test using its novel investigational PET imaging agent flurpiridaz F 18 injection (formerly known as BMS747158).
A new review showed that the protective effect of prior SARS-CoV-2 infection is at least equivalent to that of vaccination.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Douglas Lawenda, MD 2234 Colonial Blvd, Payer Contracting And Relations, Fort Myers, FL 33907-1412 Ph: (239) 931-7342 | Dr Brian Douglas Lawenda, MD 7379 W Deschutes Ave, Suite 100, Kennewick, WA 99336-7900 Ph: (509) 987-1800 |
News Archive
UNICEF warned today that serious funding shortfalls are jeopardizing its humanitarian operation in Pakistan. UNICEF is extremely concerned at the lack of funds for its water and sanitation operation, with millions of children at risk from water-borne diseases.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
Drug delivery company pSivida Corp today announced it amended and restated its Research and Development Agreement with Pfizer Inc. to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and glaucoma.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary Phase 2 data describing the methodology used to define an imaging protocol for a one-day rest-stress myocardial perfusion imaging test using its novel investigational PET imaging agent flurpiridaz F 18 injection (formerly known as BMS747158).
A new review showed that the protective effect of prior SARS-CoV-2 infection is at least equivalent to that of vaccination.
› Verified 4 days ago
Mrs. Sheila D Rege, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7379 W Deschutes Ave, Ste 100, Kennewick, WA 99336 Phone: 509-987-1800 Fax: 509-987-1808 | |
Dr. Peter K Sien, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7379 W Deschutes Ave Ste 100, Kennewick, WA 99336 Phone: 509-987-1800 Fax: 509-987-1808 | |
Dr. Sandip Arvind Patidar, MD Radiology Medicare: Medicare Enrolled Practice Location: 900 S Auburn Street, Kennewick, WA 99336 Phone: 509-586-5945 Fax: 509-586-5178 | |
Steven J Sunderland, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7221 W Deschutes Ave, Suite A, Kennewick, WA 99336 Phone: 509-374-4030 Fax: 509-374-4030 | |
Dr. Andrew Thomas Roehrig, MD Radiology Medicare: Medicare Enrolled Practice Location: 7350 W Deschutes Ave Ste A, Kennewick, WA 99336 Phone: 509-737-3371 Fax: 509-736-0958 | |
Dr. Lon Sidney Welch Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7221 W Deschutes Ave, Suite A, Kennewick, WA 99336 Phone: 509-374-4030 Fax: 509-374-8690 |